Pluristem Announces Safety of PLX Cells in Pre-Clinical Pregnancy Model

Pluristem Therapeutics (NASDAQ: PSTI ) announced today that its PLacental eXpanded (PLX) cells proved to be safe in an animal study assessing maternal and fetal toxicity. The study was conducted at the Charles River Laboratories, one of the world's leading contract research organizations. The results showed that the intramuscular